Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Aug 11, 2016
Financial News
Metabolon raises $15M in series E
...declined to comment on its plans for repurchasing shares. Metabolon's prior investors include Camden Partners,
Sumitomo Corp. Group
...
Read More
BioCentury
|
Sep 5, 2011
Company News
Astellas, Sumitomo Corp. Group deal
...is expected to close mid-September. Terms were not disclosed. Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan
Sumitomo Corp. Group
...
Read More
BioCentury
|
Jun 13, 2011
Company News
Neuralstem, Sumitomo Corp. Group deal
...Phase I testing for major depression. Terms were not disclosed. Neuralstem Inc. (NYSE-A:CUR), Rockville, Md.
Sumitomo Corp. Group
...
Read More
Items per page:
10
1 - 3 of 3
BioCentury
|
Aug 11, 2016
Financial News
Metabolon raises $15M in series E
...declined to comment on its plans for repurchasing shares. Metabolon's prior investors include Camden Partners,
Sumitomo Corp. Group
...
Read More
BioCentury
|
Sep 5, 2011
Company News
Astellas, Sumitomo Corp. Group deal
...is expected to close mid-September. Terms were not disclosed. Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan
Sumitomo Corp. Group
...
Read More
BioCentury
|
Jun 13, 2011
Company News
Neuralstem, Sumitomo Corp. Group deal
...Phase I testing for major depression. Terms were not disclosed. Neuralstem Inc. (NYSE-A:CUR), Rockville, Md.
Sumitomo Corp. Group
...
Read More
Items per page:
10
1 - 3 of 3
Previous page
Next page